# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T19:49:38.586828
**Route:** OpenRouter + LaTeX
**Tokens:** 21891 in / 1285 out
**Response SHA256:** 2fbdc2d2ea22e9c7

---

I reviewed the entire LaTeX draft focusing only on the four fatal-error categories you requested (Data-Design Alignment; Regression Sanity; Completeness; Internal Consistency). I checked every table, reported estimate, timing statement, sample-size claim, and treatment coding in the manuscript for internal contradictions or impossible values.

Summary judgment: I found no fatal errors.

Below are brief confirmations by category to document what I checked.

1) Data-Design Alignment
- Treatment timing vs data coverage: All treated cohorts included in the analysis have treatment quarter ≤ sample end (latest treatment quarter in the analysis is 2023Q1; sample ends 2023Q4). The paper explicitly excludes NY (Sep 2023) and HI (2024) from the analysis because of insufficient post-treatment quarters; that exclusion is correctly described in text and Table A.2. Max(treatment year) for included states = 2023 ≤ max(data year) 2023 → OK.
- Post-treatment observations: Reported post-quarter counts in the Treatment Timing table (Colorado 12, CT/NV 9, RI/CA/WA 4) match the 2015Q1–2023Q4 sample window—so there are post-treatment quarters for each included cohort. Event-study design appears feasible.
- Treatment definition consistency: The treatment-quarter definitions in Section 5 (Data) match Table A.2 and the timing described earlier (and the map caption). "First treated year"/quarter appears used consistently.

2) Regression Sanity
- Standard errors and coefficients: All reported coefficients and standard errors in the main tables and event-study table are numerically plausible (coefficients generally in log-points around ±0.1 or less, SEs small and of plausible magnitude). No SE > 1000, no SE > 100×|coef|, no extremely large coefficients for log outcomes, and no negative SEs.
- R² / impossible values: The tables do not report any R² outside [0,1], nor any "NA", "NaN", "Inf", or other error strings in tables. Event-study coefficients reported with SEs look reasonable.
- Cluster counts and observation counts are reported and of reasonable size; state-cluster count is 17 and pair-cluster count is 129 where appropriate.

3) Completeness
- No placeholder tokens (NA, TBD, TODO, XXX, PLACEHOLDER) appear in tables or notes.
- Required elements present: sample sizes (Observations, Counties/Pairs, Clusters) are reported in main tables and appendices; standard errors/confidence intervals present; references to figures/tables correspond to included labels in the source.
- Analyses promised in the text (Callaway–Sant'Anna, TWFE, border pairs, gender effects, robustness/placebo) are shown in tables/figures or discussed with estimates; robustness and placebo results are reported.

4) Internal Consistency
- Numbers cited in the abstract and introduction match table values (e.g., Callaway–Sant'Anna ATT +1.0% (SE=1.4%) in abstract and Table 3; border +11.5% (SE=2.0) matches the table and decomposition described).
- Treatment timing is consistent across text, Table A.2, and map caption; exclusions (NY, HI) are consistently explained.
- Descriptions of the border estimate being a level difference vs. the DiD change (+3.3%) are consistent across text, figure captions, and Table 6/7 descriptions.
- Specification labels and what they represent (C-S, TWFE, border, DDD for sex) are used consistently.

Because the instructions request that I report any fatal errors and provide a PASS only if there are zero fatal errors, and because I did not find any violations that meet the "fatal" criteria you specified, my verdict is:

ADVISOR VERDICT: PASS